4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-17-000308
EVP, CHIEF COMMERCIAL OFFICER sold 7,856 shares at $39.65 ($311,490)
- EVP, CHIEF COMMERCIAL OFFICER acquired 7,856 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER | 2017-02-21 | Option exercise | +7,856 | $34.45 | $270,639 | 9,527 | D |
| Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER | 2017-02-21 | Sale | −7,856 | $39.65 | $311,490 | 1,671 | D |
| Derivatives | |||||||
| Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER | 2017-02-21 | Option exercise · Stock Option (right to buy) | −7,856 | 82,500 | D | ||
| Open-market sales · 7,856 sh · avg $39.65 · $311,490 | |||||||
Loading xslF345X03/form4-02232017_030207.xml…